JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
salesforce.com (CRM) PT Raised to $140 at JMP Securities
-
National General Holdings (NGHC) PT Raised to $30 at JMP Securities
-
AxoGen (AXGN) to Offer 2M Shares
-
Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
AxoGen Announces Proposed Public Offering of Common Stock
-
AxoGen Announces Proposed Public Offering of Common Stock
-
Arbor Realty Trust (ABR) PT Raised to $10.50 at JMP Securities
-
Tyler Tech (TYL) PT Raised to $225 at JMP Securities
-
Sarepta Therapeutics (SRPT) PT Lowered to $90 at JMP Securities
-
BlackLine (BL) PT Raised to $47 at JMP Securities
-
Paylocity Holding (PCTY) PT Raised to $62 at JMP Securities
-
Pacira Pharmaceuticals (PCRX) PT Lowered to $56 at JMP Securities
-
Concert Pharmaceuticals (CNCE) PT Raised to $26 at JMP Securities
-
SD-WAN Market Leader Aryaka Selected Among Finalists for Marketers That Matter® Award for Tripling Revenue in Last Three Years
-
SD-WAN Market Leader Aryaka Selected Among Finalists for Marketers That Matter® Award for Tripling Revenue in Last Three Years
-
SD-WAN Market Leader Aryaka Selected Among Finalists for Marketers That Matter® Award for Tripling Revenue in Last Three Years
-
Karyopharm Therapeutics (KPTI) Prices 9.15M Share Common Offering at $14.75/Sh
-
Taylor Morrison Home (TMHC) PT Lowered to $29 at JMP Securities
-
The Hanover Insurance Group (THG) PT Raised to $130 at JMP Securities
-
Bandwidth Inc. (BAND) PT Raised to $45 at JMP Securities
-
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
-
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
-
JMP Group Reports First Quarter 2018 Financial Results
-
DocuSign Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
UPDATE: JMP Securities Reinstates Incyte (INCY) at Market Outperform, 'Near-term Catalyst in GVHD to Provide a Boost to Valuation'
-
Retrophin (RTRX) PT Raised to $35 at JMP Securities
-
Regional Management (RM) PT Raised to $42 at JMP Securities
-
GrubHub Inc. (GRUB) PT Raised to $103 at JMP Securities
-
Zendesk (ZEN) PT Raised to $55 at JMP Securities
-
Ultimate Software (ULTI) PT Raised to $280 at JMP Securities
-
Karyopharm Therapeutics (KPTI) Commences $125M Common Stock Offering
-
Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
-
Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
-
CommVault Systems (CVLT) PT Raised to $73 at JMP Securities Citing Increased CY 2019 Recurring Revenue Estimate
-
JMP Securities Resumes Chemed (CHE) at Market Perform
-
JMP Securities Downgrades SteadyMed (STDY) to Market Perform Following Acquisition
-
Varonis Systems (VRNS) PT Raised to $71 at JMP Securities
-
AxoGen, Inc. (AXGN) PT Raised to $43 at JMP Securities
-
Apptio (APTI) PT Raised to $32 at JMP Securities
-
AxoGen, Inc. Reports 2018 First Quarter Financial Results
-
AxoGen, Inc. Reports 2018 First Quarter Financial Results
-
Maxim Group LLC Expands Equity Research Platform With the Appointment of a Senior Biotechnology Analyst
-
Engagio Expands Marketing Orchestration Capabilities to Support Multi-Channel ABM Initiatives
-
SVB Financial (SIVB) PT Raised to $345 at JMP Securities
-
DocuSign (DOCU) IPO Opens 31% Higher
-
JMP Group to Report First Quarter Financial Results on May 2, 2018
-
JMP Securities Downgrades Symantec (SYMC) to Market Perform
-
Lazard (LAZ) PT Raised to $66 at JMP Securities
-
CyberArk Software (CYBR) PT Raised to $63 at JMP Securities

